News June 23, 2018 - ScriptCenter Secures Valuable Pharmacy Customers Read More June 23, 2018 - Two-year Data from ViaCyte’s STEP ONE Clinical Trial Presented at ADA 2018 Read More June 5, 2018 - Asteres Inc. Receives Unanimous Approval from Texas Board of Pharmacy Read More May 14, 2018 - Michael Paul, Ph.D., CEO of Lineagen, Inc., Nominated for Prestigious Entrepreneur of the Year Award Read More May 14, 2018 - Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Read More May 14, 2018 - Asteres Inc. Receives Unanimous Approval from Texas Board of Pharmacy Read More May 14, 2018 - ViaCyte to Present at the American Diabetes Association’s 78th Scientific Sessions Read More May 1, 2018 - CalciMedica Names Two Senior Executives to its Board of Directors Read More April 17, 2018 - ViaCyte Awarded NIH SBIR Grant to Support In Vitro Development of Stem Cell-Derived Functional Human Pancreatic Beta Cells Read More April 9, 2018 - DalCor Pharmaceuticals Announces Dr. Fouzia Laghrissi-Thode as Chief Executive Officer Read More